抑制剂溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 产品编号 | 图片 | 产品描述 | 分子式 | 加入购物车 | |
|---|---|---|---|---|---|
|
PH-797804，98% | C22H19BrF2N2O3 | |||
|
|
|||||
|
TWS119，98% | C18H14N4O2 | |||
|
|
|||||
|
MEK162 (ARRY-162, ARRY-438162)，98% | C17H15BrF2N4O3 | |||
|
|
|||||
|
Turofexorate isopropyl，99% | C25H24F2N2O3 | |||
|
|
|||||
|
AS-605240，98% | C12H7N3O2S | |||
|
|
|||||
|
STF-31，98% | C23H25N3O3S | |||
|
|
|||||
|
Pirarubicin，99% | C32H37NO12 | |||
|
|
|||||
|
VX-702，99% | C19H12F4N4O2 | |||
|
|
|||||
|
Isradipine，99% | C19H21N3O5 | |||
|
|
|||||
|
PHA-848125，98% | C25H32N8O | |||
|
|
|||||
|
BIIB021，98% | C14H15ClN6O | |||
|
|
|||||
|
Ivacaftor (VX-770)，99% | C24H28N2O3 | |||
|
|
|||||
|
IKK-16 (IKK Inhibitor VII)，99% | C28H29N5OS | |||
|
|
|||||
|
Vismodegib (GDC-0449)，99% | C19H14Cl2N2O3S | |||
|
|
|||||
|
CCT128930，98% | C18H20ClN5 | |||
|
|
|||||
|
Enzalutamide，99% | C21H16F4N4O2S | |||
|
|
|||||
|
Oprozomib (ONX 0912)，99% | C25H32N4O7S | |||
|
|
|||||
|
VX-809 (Lumacaftor)，99% | C24H18F2N2O5 | |||
|
|
|||||
|
OSI-027，98% | C21H22N6O3 | |||
|
|
|||||
|
GSK690693，≥98% | C21H27N7O3 | |||
|
|
|||||
|
Cisatracurium Besylate，98% | C53H72N2O12·2C6H5O3S | |||
|
|
|||||
|
Latrepirdine，≥96% | C21H25N3·2HCl | |||
|
|
|||||
|
PF-04457845，≥98% | C23H20F3N5O2 | |||
|
|
|||||
